CAPN3 and muscular dystrophy: Furthermore, gene-transfer therapies for other types of muscular dystrophies (CAPN3, SGCB, SGCA, DYSF, SGCG and ANO5) are burgeoning (Gene Therapy Engine; Chu and Moran, 2018).1